Jpmorgan Chase & CO Cortexyme, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Cortexyme, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 548 shares of CRTX stock, worth $706. This represents 0.0% of its overall portfolio holdings.

Number of Shares

548

Previous 469 16.84%

Holding current value

$706

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	BUY	N/A	79 Added 16.84%	548 $0
Q3 2024 Nov 08, 2024	BUY	N/A	79 Added 16.84%	548 $0
Q2 2024 Dec 26, 2024	SELL	N/A	-79 Reduced 14.42%	469 $0
Q1 2024 Dec 26, 2024	SELL	N/A	-79 Reduced 14.42%	469 $0
Q4 2023 Dec 26, 2024	SELL	N/A	-79 Reduced 14.42%	469 $0
Q4 2022 Feb 13, 2023	SELL	N/A	-232,399 Reduced 99.8%	469 $0
Q3 2022 Nov 14, 2022	SELL	$1.29 - $2.52 $431,090 - $842,131	-334,179 Reduced 58.93%	232,868 $310,000
Q2 2022 Aug 11, 2022	SELL	$2.22 - $6.7 $51,890 - $156,605	-23,374 Reduced 3.96%	567,047 $1.26 Million
Q1 2022 May 11, 2022	BUY	$4.18 - $13.39 $2.43 Million - $7.77 Million	580,317 Added 5743.44%	590,421 $3.65 Million
Q4 2021 Feb 10, 2022	SELL	$11.35 - $97.17 $38,646 - $330,863	-3,405 Reduced 25.21%	10,104 $128,000
Q3 2021 Nov 12, 2021	BUY	$52.0 - $120.21 $702,468 - $1.62 Million	13,509 New	13,509 $1.24 Million

Others Institutions Holding CRTX

# of Institutions

Shares Held

5.3M

Call Options Held

90.8K

Put Options Held

View Full List

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Cortexyme, Inc. Transaction History